Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: April 12, 2022
Long
COVID
remains
a
broadly
defined
syndrome,
with
estimates
of
prevalence
and
duration
varying
widely.
We
use
data
from
rounds
3-5
the
REACT-2
study
(n
=
508,707;
September
2020
-
February
2021),
representative
community
survey
adults
in
England,
replication
round
6
97,717;
May
2021)
to
estimate
identify
predictors
persistent
symptoms
lasting
12
weeks
or
more;
unsupervised
learning
cluster
individuals
by
reported
symptoms.
At
3-5,
37.7%
experienced
at
least
one
symptom,
falling
21.6%
6.
Female
sex,
increasing
age,
obesity,
smoking,
vaping,
hospitalisation
COVID-19,
deprivation,
being
healthcare
worker
are
associated
higher
probability
Asian
ethnicity
lower
probability.
Clustering
analysis
identifies
subset
participants
predominantly
respiratory
Managing
long-term
sequelae
COVID-19
will
remain
major
challenge
for
affected
their
families
health
services.
JAMA,
Journal Year:
2021,
Volume and Issue:
325(19), P. 2015 - 2015
Published: April 7, 2021
This
cohort
study
describes
COVID-19–related
symptoms
persisting
8
months
after
SARS-CoV-2
infection
among
Swedish
health
care
workers
and
self-reported
effects
of
the
residual
on
respondents'
home,
work,
social
function.
Brain Behavior and Immunity,
Journal Year:
2021,
Volume and Issue:
97, P. 328 - 348
Published: July 30, 2021
It
has
become
evident
that
coronavirus
disease
2019
(COVID-19)
a
multi-organ
pathology
includes
the
brain
and
nervous
system.
Several
studies
have
also
reported
acute
psychiatric
symptoms
in
COVID-19
patients.
An
increasing
number
of
are
suggesting
deficits
may
persist
after
recovery
from
primary
infection.
In
current
systematic
review,
we
provide
an
overview
available
evidence
supply
information
on
potential
risk
factors
underlying
biological
mechanisms
behind
such
sequelae.
We
performed
search
for
sequelae
patients
using
databases
PubMed
Embase.
Included
all
contained
follow-up
period
provided
quantitative
measures
mental
health.
The
was
June
4th
2021.
1725
unique
were
identified.
Of
these,
66
met
inclusion
criteria
included.
Time
to
ranged
immediately
hospital
discharge
up
7
months
discharge,
participants
spanned
3
266,586
participants.
Forty
anxiety
and/or
depression,
20
symptoms-
or
diagnoses
post-traumatic
stress
disorder
(PTSD),
27
cognitive
deficits,
32
articles
found
fatigue
at
follow-up,
sleep
disturbances
23
studies.
Highlighted
severity,
duration
symptoms,
female
sex.
One
study
showed
abnormalities
correlating
with
several
inflammatory
markers
correlate
symptoms.
Overall,
results
this
review
suggest
survivors
but
generally
improve
over
time.
Medicina,
Journal Year:
2021,
Volume and Issue:
57(5), P. 418 - 418
Published: April 26, 2021
Background
and
Objectives:
Long
COVID
defines
a
series
of
chronic
symptoms
that
patients
may
experience
after
resolution
acute
COVID-19.
Early
reports
from
studies
with
long
suggests
constellation
similarities
to
another
medical
illness—myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS).
A
review
study
comparing
contrasting
ME/CFS
reported
yield
mutualistic
insight
into
the
characterization
management
both
conditions.
Materials
Methods:
systemic
literature
search
was
conducted
in
MEDLINE
PsycInfo
through
31
January
2021
for
related
symptomatology.
The
accordance
PRISMA
methodology.
Results:
Twenty-one
were
included
qualitative
analysis.
by
compared
list
compiled
multiple
case
definitions.
Twenty-five
out
29
known
at
least
one
selected
study.
Conclusions:
symptomatology
suggest
many
overlaps
clinical
presentation
ME/CFS.
need
monitoring
treatment
post-COVID
is
evident.
Advancements
standardization
research
methodologies
would
improve
quality
future
research,
allow
further
investigations
differences
between
AJP Cell Physiology,
Journal Year:
2021,
Volume and Issue:
322(1), P. C1 - C11
Published: Nov. 24, 2021
SARS-CoV-2
has
rapidly
spread
across
the
globe
and
infected
hundreds
of
millions
people
worldwide.
As
our
experience
with
this
virus
continues
to
grow,
understanding
both
short-term
long-term
complications
infection
grow
as
well.
Just
there
is
heterogeneity
in
acute
infectious
phase,
seen
following
COVID-19
illness.
The
purpose
review
article
present
current
literature
regards
epidemiology,
pathophysiology,
proposed
management
algorithms
for
various
sequelae
that
have
been
observed
each
organ
system
SARS-CoV-2.
We
will
also
consider
future
directions,
newer
variants
their
potential
impact
on
observed.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: April 12, 2022
Long
COVID
remains
a
broadly
defined
syndrome,
with
estimates
of
prevalence
and
duration
varying
widely.
We
use
data
from
rounds
3-5
the
REACT-2
study
(n
=
508,707;
September
2020
-
February
2021),
representative
community
survey
adults
in
England,
replication
round
6
97,717;
May
2021)
to
estimate
identify
predictors
persistent
symptoms
lasting
12
weeks
or
more;
unsupervised
learning
cluster
individuals
by
reported
symptoms.
At
3-5,
37.7%
experienced
at
least
one
symptom,
falling
21.6%
6.
Female
sex,
increasing
age,
obesity,
smoking,
vaping,
hospitalisation
COVID-19,
deprivation,
being
healthcare
worker
are
associated
higher
probability
Asian
ethnicity
lower
probability.
Clustering
analysis
identifies
subset
participants
predominantly
respiratory
Managing
long-term
sequelae
COVID-19
will
remain
major
challenge
for
affected
their
families
health
services.
